AI in Cell Line Development: What Machine Learning Can and Cannot Do Yet

AI in Cell Line Development: What Machine Learning Can and Cannot Do Yet AI is dominating biotech headlines, and regulators are paying attention. In January 2025, FDA released its first draft guidance on AI for drug and biologic regulatory decisions. Meanwhile, researchers are testing AI in cell line development to identify strong clones sooner. The … Continue reading AI in Cell Line Development: What Machine Learning Can and Cannot Do Yet

Cell Line Technology Transfer: What Actually Travels With the Vial

Cell Line Technology Transfer: What Actually Travels With the Vial Trade policy just pushed cell line technology transfer up the priority list. On September 23, 2026, Commerce’s Bureau of Industry and Security published procedures implementing Proclamation 11020. Those procedures took effect on September 29, 2026. The notice sets a zero tariff rate for qualifying specialty … Continue reading Cell Line Technology Transfer: What Actually Travels With the Vial

Protein Purification Services: What Buyers Should Look For in a Downstream Processing Partner

Protein Purification Services: What Buyers Should Look For in a Downstream Processing Partner Protein purification services are the bridge between a productive cell culture and a usable protein product. Upstream production creates the material, but downstream processing determines whether that material meets the purity, activity, and quality specifications your program actually needs. Choosing a partner … Continue reading Protein Purification Services: What Buyers Should Look For in a Downstream Processing Partner